SELLAS Life Sciences Announces Update on Phase 3 REGAL Clinical Trial Evaluating Lead…
– Overall Survival Observed in Pooled Patient Data to Date Leads to Changes in Statistical Analysis Plan: Interim Analysis Now at 60 Events and Final Analysis Now at 80 Events – – 3D…